Abstract. In this paper, we show that [3COP is present on endosomes and is required for the formation of vesicles which mediate transport from early to late endosomes. Both the association of 13COP to endosomal membranes as well as transport vesicle formation depend on the lumenal pH. We find that ~COP, but not ",/COP, is also associated to endosomes, and that this association is also lumenal pH dependent. Our data, thus, indicate that a subset of COPs is part of the mechanism regulating endosomal membrane transport, and that membrane association of these COPs is controlled by the acidic properties of early endosomes, presumably via a trans-membrane pH sensor.
Thus, the COP and COPII coats may be associated to either two parallel or two sequential transport steps from the ER to the Golgi. These coats may also support transport in opposite directions, as suggested by recent studies showing that retrieval of di-lysine tagged proteins to the ER depends on COPs (Letourneur et al., 1994) .
Except for the AP2/clathrin coat at the plasma membrane, relatively little is known about the possible involvement of coat proteins in the endocytic pathway. At the electron microscope level, early endosomal membranes were shown to contain clathrin-coated pits with a diameter smaller than on the plasma membrane; these pits were proposed to mediate membrane recycling back to the cell surface (Killisch et al., 1992) . Nonclathrin-coated domains have also been observed on early endosomal membranes (Par*on, R., unpublished result), but the identity and role of these putative coat proteins are unknown. Whereas GTP-binding proteins of the ARF/sar family regulate coat assembly at different steps of the biosynthetic pathway (D'Enfert et al., 1991; Orci et al., 1993a; Stammes and Rothman, 1993) , their role in the endocytic pathway is not clear. In vitro studies may suggest that an ARF protein is involved in endosome fusion (Lenhard et al., 1992) , while overexpression of a mutant ARF6 defective in nucleotide binding caused accumulation of nonclathrin-coated structures on peripheral tubules, and reduced transferrinreceptor recycling (D'Souza-Schorey et al., 1994; Peters et al., 1994) . Brefeldin A, a drug which inhibits the Golgiassociated ARF1 exchange factor (Donaldson et al., 1992; Helms and Rothman, 1992) , was shown to affect the morphology of endosomes (Lippincott-Schwartz et al., 1991; Tooze and Hollinshead, 1991; Wood and Brown, 1992) , but the molecular events causing these changes are not clear. Finally, expression of ~COP, a component of the COP coat (Hara- Kuge et al., 1994) , could correct pleiotro-pic transport defects, including in the endocytic pathway, in a mutant CHO cell line (Guo et al., 1994) .
In previous studies, we have observed that tracers endocytosed in BHK cells first appear in early endosomes, then in intermediate vesicles with the typical morphology of multivesicular endosomes, and finally in late endosomes . Our in vitro studies indicate that these vesicles, which we term endosomal carrier vesicles (ECVs) 1, are obligatory transport intermediates between early and late endosomes, since ECVs are only fusogenic with late endosomes, but not with early endosomes nor with each other Bomsel et al., 1990; Aniento et al., 1993a) . We also observed that neutralization of the vacuolar pH with bafilomycin A1, a specific inhibitor of the vacuolar ATPase (Bowman et al., 1988) , blocks ECV formation in vivo (Clague et al., 1994) . The former treatment had no effect on internalization into and recycling from early endosomes in vivo, or on endosome fusion properties in vitro. In the present paper, we have investigated the mechanisms of ECV formation from early endosomes using an in vitro assay. Our data show that ~COP is associated to early endosomes and is involved in ECV formation. Our observations also suggest that some, but not all, COPs are involved in this process, and that coat formation is controlled by the acidic properties of early endosomes, presumably via a trans-membrane pH sensor.
Materials and Methods

Cells, Viruses, and Immunological Reagents
Monolayers of BHK-21 cells were grown and maintained as described . For each experiment, a minimum of 6 × 10 cm Petri dishes were seeded 16 h before use. Vesicular stomatitis virus (VSV) was produced as described . All manipulations of the cells were at 4°C, except when indicated. The P5D4 monoclonal antibody against the cytoplasmic domain of the spike glycoprotein G of VSV (Kreis, 1986 ) was a gift of T. Kreis (University of Geneva, Geneva, Switzerland), as well as the M3A5, maD, A1, El, and D1 antibodies against 13COP peptides (Allan and Kreis, 1986; Pepperkok et al., 1993) . The CM1A10 anti-coatomer antibody (Orci et al., 1993b) and the anti-~COP antibody (Hara- Kuge et al., 1994) were gifts from J. Rothman (Sloan-Kettering Institute, New York, NY). The antibody against ~COP (Stenbeck et al., 1992 ) was a gift from F. Wieland (Ruprecht Karls University, Heidelberg, Germany). The antibody against ERGIC53 was a gift from H.-P. Hauri (Biocenter, Basel, Switzerland) . The monoclonal antibodies against rab5a and rab3a were gifts from R. Jahn (Yale University, New Haven, CT), and the monoclonal antibody against the transferrin receptor was a gift from I. Trowbridge (Salk Institute, San Diego, CA). The antibody against annexinII was a gift from V. Gerke (University of MOnster, MOnster, Germany).
Subcellular Fractionation of Endosomes
Endosomes were separated from each other and from the plasma membrane using a step flotation gradient, as described Gorvel et al., 1991; Aniento et al., 1993a; Emans et al., 1993) . Briefly, cells were homogenized gently to limit damage that may be caused to endosomes, and a postnuclear supernatant (PNS) was prepared. The PNS was adjusted to 40.6% sucrose, 3 mM imidazole, pH 7.4, loaded at the bottom of an SW60 tube, and then overlaid sequentially with 35 and 25% sucrose solutions in 3 mM imidazole, pH 7.4, and then with homogenization buffer 1. Abbreviations used in this paper: bHRP, biotinylated HRP; ECV, endosomal carrier vesicle; FI r, floated fraction; HB, homogenization buffer; HSP, high-speed pellet; PF, pelleted fraction; PNS, postnuclear supernatant; VSV, vesicular stomatitis virus.
(HB; 250 mM sucrose, 3 mM imidazole, pH 7.4). The gradient was centrifuged for 60 min at 35,000 rpm using an SW60 rotor. Early endosomes were then collected at the 35%/25% interface and both ECVs and late endosomes at the 25%/HB interface. In immunoisolation experiments, endosomal fractions were prepared using the same gradient, except that 16% sucrose and 10% sucrose in D20 were used instead of 35 and 25% sucrose, respectively .
Early and late endosomes were immunoisolated using as antigen the cytoplasmic domain of the spike glycoprotein G of VSV Howell et al., 1989; Aniento et al., 1993a; Emans et al., 1993) . Briefly, the G protein was implanted into the plasma membrane by low pH-mediated fusion of the viral envelope with the plasma membrane and then internalized for 5 min at 37°C to label early endosomes or for 45 min at 37°C to label late endosomes. The cells were then homogenized and fractionated in the gradient, as described above. Early and late endosomal fractions were collected and used as input in immunoisolation experiments. For immunoisolation, we used magnetic beads (M-450 Dynabeads) with coupled antibodies against mouse IgG as solid support and the P5D4 antibody against the cytoplasmic domain of the G protein as specific antibody (Kreis, 1986) . Alternatively, endosomes were immunoisolated using the maD or the M3A5 antibody against 13COP as specific antibody.
In Vitro Formation of ECVs from Early Endosomes
To provide a marker of the early endosomal content (Aniento et al., 1993a; Emans et al., 1993; Gruenberg et al., 1989) , cells were incubated for 5 min in the presence of 5 mg/ml HRP. The cells were then homogenized and early endosomes were separated from ECVs and late endosomes after flotation on the gradient (see above). The early endosomal fraction was then diluted to ~0.2 mg protein/ml with HB, adjusted to 12.5 mM Hepes, pH 7.0, 1 mM DTF, 1.5 mM MgOAc, 60 mM KCI, and supplemented with an ATP regenerating system (Gruenberg and Howell, 1986) and 4 mg/ml rat liver cytosol (Aniento et al., 1993b) . In the assay, the mixture, containing 300-500 l~g of early endosomal protein in a final volume of 1.4-2.3 ml, was incubated for 30 min at 37°C. After the incubation, the mixture containing both donor early endosomes and vesicles formed in vitro was brought to 25% sucrose, 3 mM imidazole, pH 7.4, loaded at the bottom of an SW60 tube and overlaid with HB. After 1 h centrifugation at 35,000 rpm, donor early endosomes (pelleted fraction; PF) and budded vesicles (floated fraction; FF) were recovered from the pellet and the 25 % sucrose/HB interface, respectively. Both fractions were re-centrifuged for 30 min at 100,000 g to sediment membranes, and the HRP activity was quantified in the pellets. For SDS gel electrophoresis, membranes were washed during a second centrifugation step in HB containing 150 mM NaCI to remove loosely bound cytosolic factors, before solubilization in gel sample buffer.
In some experiments, the cytosol was depleted of coatomer using the CM1A10 anti-coatomer antibody, as reported by Orci et al. (1993b) . The cytosol was incubated with the antibody for 90 min at 4°C and then for an additional 60-rain time period with protein A~Sepharose coupled to rabbit anti-mouse IgG. After removal of the immune complex, both 13 and eCOP were reduced to -~15-20% of the original amounts. In controls, the anti-13COP antibody was replaced by an irrelevant antibody (P5D4). A fraction highly enriched in coatomer was prepared by high speed centrifugation (200,000 g, 2 h) of rat liver cytosol, as established by F. Wieland (Ruprecht Karls University, Heidelberg, Germany). The high-speed supernatant then retained only ~-20% of both 13 and eCOP. The high-speed pellet (HSP) enriched in coatomer was resuspended in HB and used in the assay.
In Vitro Fusion of ECVs with Late Endosomes
The fusion properties of vesicles formed in vitro were measured using an assay we have established Bomsel et al., 1990; Gorvel et al., 1991; Aniento et al., 1993a) . Formation of vesicles in vitro was as above, except that biotinylated HRP (bHRP) was used to label the vesicle content, instead of HRP. Then, ECVs formed in vitro were separated from donor membranes by flotation as described above, except that the reaction mixture was loaded onto a 35% sucrose cushion in 3 mM imidazole, pH 7.4, to avoid pelleting of the donor membranes. Thus, donor early endosomal membranes (PF) were collected at the interface between 35 and 25% sucrose, and ECVs formed in vitro (FF) at the interface between 25% sucrose and homogenization buffer. In control experiments, early endosomes labeled with bHRP internalized for 5 min at 37°C were prepared as above using the gradient. The total bHRP activity of each fraction used in the fusion assay was always identical, so that experiments could be directly compared. In parallel, early or late endosomes were labeled with avidin after incubation at 37°C for 5 min, or 5 min followed by a 40-rain chase in marker-free medium, respectively Gorvel et ai., 1991; Aniento et al., 1993a) . After homogenization, a PNS was prepared and used in the fusion assay, as described . In the assay, bHRP-labeled vesicles formed in vitro (50 p,1 containing 5-10 p,g protein) were mixed with 70 p~l PNS containing avidinlabeled endosomes, and then supplemented with 30 Ixl rat liver cytosol (20 mg protein/ml), an ATP-regenerating or -depleting system, 0.05 mg/ml biotinylated insulin, 60 mM KOAc, 1.5 mM MgOAc, 1 mM DTT, and 12.5 mM Hepes, pH 7.4, and the mixture was incubated for 45 min at 37°C. In some experiments, endogenous tubulin was polymerized in the assay using 20 IxM taxol (Bomsel et al., 1990; Aniento et al., 1993a) . Then the avidin-bHRP complex formed upon membrane fusion was extracted in detergent, immunoprecipitated with anti-avidin antibodies and the enzymatic activity of bHRP was quantified. To calculate fusion efficiency, this value was expressed as a percentage of the total amount of avidin-bHRP complex formed in the presence of detergent and in the absence of biotinylated insulin.
Electron Microscopy
For electron microscopic localization studies, BHK cells were grown on polylysine-coated coverslips for 2 d before the experiment. The cells were washed and incubated with 10 mg/ml HRP for 10 min at 37°C to label early endosomes. They were then washed with cold PBS and transferred to ice. Rip-off of the dorsal surface was performed as described by De Curtis and Simons (1989) . Briefly, a nitrocellulose filter was laid on top of the coverslips in contact with the cells. After applying slight pressure to the nitrocellulose using a bent glass pipette, the nitrocellulose was removed. All the following steps, before fixation, were performed on ice. The cells were then incubated for 10 min in 12.5 mM Hepes, pH 7.0 buffer, containing 75 mM KC1, 1.5 mM MgOAc and 0.1% BSA, and then incubated in the same buffer for 30 rain with either the M3A5 anti-13COP antibody or with a control monoclonal antibody at exactly the same concentration. After washing the cells over 30 min, they were then incubated with gold-labeled second antibodies (Aurion, Wageningen, The Netherlands). The cells were washed to remove unbound gold, fixed in 2.5% glutaraldehyde in 50 mM cacodylate, and then processed for Epon embedding as previously described (Parton et al., 1992) . Sections were cut parallel to the substratum and viewed without further contrasting.
When analyzed in plastic sections, fractions containing HRP-labeled donor membranes (PF) or vesicles formed in vitro (FF) were prepared as described above, and centrifuged for 30 min at 100,000 g. The membrane pellets were fixed, reacted with diaminobenzidine, and processed for electron microscopy as described (Parton et al., 1989; Bomsel et al., 1990) . In some experiments, the assay measuring vesicle formation was carried out in the presence of GTP~S and M3A5 anti-13COP antibody. Then, rabbit anti-mouse IgG and protein A-gold were added. Membranes were collected by centrifugation in a sucrose step flotation gradient at the 35-10% interface and then re-centrifuged for 30 min at 100,000 g. The membrane pellets were fixed, reacted with diaminobenzidine, and processed for electron microscopy.
Analytical Techniques
Quantification of protein was according to (Bradford, 1976) . Western blot analysis was carried out using peroxidase-conjugated sheep anti-mouse or goat anti-rabbit IgG as secondary antibodies and detected by chemiluminescence using the ECL reagent (Amersham Corp., Arlington Heights, IL). Western blots exposed in the linear range of detection, as established with controls, were quantitated using a GS300 transmitance/reflectance scanning densitometer (Hoefer Scientific Instruments, San Francisco, CA).
Results
flCOP (or a Closely Related Homologue) Is Present in Endosomal Fractions
We have tested whether 13COP could be detected on endosomes of BHK cells. As a first step, we have analyzed endosomal fractions obtained by flotation in a step gradient which we have established. In this gradient, early endosomes, containing annexinlI and the small GTPase rab5, equilibrate at the interface between two cushions of 35 and 25% sucrose, whereas late endosomes, containing the rab7 protein as well as the mannose-6-phosphate receptor and lysosomal glycoproteins, are found at a lighter position corresponding to the interface between 25 and 8.5% sucrose Gorvel et al., 1991; Aniento et al., 1993a; Emans et al., 1993) . A detailed analysis of the in vitro fusion properties and protein composition of these fractions revealed that ECVs equilibrate at the same position as late endosomes (Aniento et al., 1993a) .
A Western blot analysis revealed the presence of proteins migrating at the position of 13COP and ¢COP in both early and late endosomal fractions ( Fig. 1 A, EE and LE, respectively). In contrast, these fractions did not contain detectable amounts of ~/COP. Previously, the bulk of 13COP was shown to localize to early stages of the biosynthetic pathway after immunogold labeling of cryosections using an antibody raised against a 13COP peptide (Duden et al., 1991; Pepperkok et al., 1993) . We therefore analyzed the distribution of the intermediate compartment between ER and Golgi in our gradient, using antibodies against ERGIC53 (Schweizer et al., 1988) . The bulk of ERGIC53, I~COP, and ¢COP was recovered, as expected, in the same fraction (heavy membranes, Fig. 1 A, HM), at the interface between the load and the 35% sucrose cushion, well separated from endosomes. Quantification of the gels showed that the early endosomal fraction contained only -~10% of the amounts of ERGIC53 present in the HM fraction and <5% of 7COP, but 55-70% of ¢ and 13COP (Fig. 1 B) . It is, however, not clear whether these values really reflect the intracellular distribution of 13 and ~COP, or whether the endosomal forms of these proteins are preferentially recognized by the antibodies we used. Moreover, both and 13COP were also present in late endosomal fractions, but neither ERGIC53 nor ~/COP (even after long exposures of the gels). To ensure that the presence of COPs in endosomal fractions did not reflect spurious membrane association of the protein after homogenization, we prepared mitochondria and Golgi/endosome fractions from rat liver (Aniento et al., 1993b) . A Western blot analysis showed that 13COP was indeed present in the latter fraction, as expected, but absent from the mitochondrial fraction (not shown). These observations may suggest that 13 and ¢COP, but not ~/COP, are associated to endosomes.
Immunoisolation of Early Endosomes
We then used immunoisolation to determine whether 13 and ~COP were indeed present on early endosomes Howell et al., 1989; Aniento et al., 1993a; Emans et al., 1993) . The spike glycoprotein G of VSV was implanted into the plasma membrane by low pH-mediated fusion of the viral envelope with the plasma membrane, and then internalized for 5 rain at 37°C to label early endosomes. After homogenization, endosomes were fractionated on the gradient and then immunoisolated on magnetic beads (Dynabeads M-450) with bound antibodies against the cytoplasmic domain of the G protein (Kreis, 1986) . As shown in Fig. 1 A, both 13 and ¢COP, but neither ERGIC53 nor ~/COP, were specifically associated to im- Figure 1 . COPs in endosomal fractions. (A) The distribution of COPs and ERGIC53 was studied in BHK cytosol and in BHK subcellular fractions by SDS-PAGE followed by Western blotting, using antibodies against ERGIC53, ¢ or ~/COP, and the M3A5 antibody against [3COP. The PNS was loaded at the bottom of a sucrose flotation gradient, and, after centrifugation, fractions were collected: heavy membranes (HM), 40.6%/35% interface; early endosomes (EE) 35%/25% interface; late endosomes (LE) 25% sucrose/homogenization buffer interface. In all lanes, 15 p,g protein was loaded. Early endosomes were further purified from 60 i~g EE fraction by immunoisolation (II-EE). Then, the VSV-G glycoprotein was implanted into the plasma membrane and then internalized for 5 min at 37°C. After the gradient, early endosomes were retrieved using anti-mouse magnetic beads without (control, ctrl.) munoisolated early endosomal membranes. We then tested whether [3 and eCOP association to endosomes was, as is the case in the biosynthetic pathway, sensitive to GTP~/S. As shown in Fig. 1 C, the amounts of [3 and ¢COP present on immunoisolated early endosomes were significantly increased after incubation in the presence of cytosol and GTP~/S, indicating that C O P recruitment onto endosomal or biosynthetic membranes share some mechanistic similarities.
As a next step, we investigated whether early endosomes could also be immunoisolated using two different anti-[3COP antibodies (M3A5 or maD). The antibodies were bound to the same solid support and the complex was added to endosomal fractions which had been collected from the gradient, as above. In these experiments, we used horseradish peroxidase internalized for 5 min at 37°C as marker of the early endosomal content, and the transferrin receptor (Hopkins and Trowbridge, 1983; Trowbridge et al., 1993) as well as the small GTPase rab5 (Chavrier et al., 1990) , as markers of early endosomal membranes. Fig. 1 (D and E) shows that the three markers were specifically retrieved with either anti-[3COP antibody, but not with control antibodies nor with antibodies recognizing the clathrin-associated [31 adaptin as well as the [32 adaptin, which has some homology to [3COP (Duden et al., 1991) . Altogether, these experiments show that [3 and ¢COP, but not ~/COP, are present on early endosomal membranes.
Electron Microscopy Analysis of flCOP on Early Endosomes
We then investigated whether [3COP could be detected on early endosomal membranes by electron microscopy. Since neither the M3A5 nor the maD antibody recognized their antigen on cryosections, we used a pre-embedding labeling technique. Cells were first incubated in the presence of H R P for 10 rain at 37°C, to label the early endosomal lumen, and then the dorsal surface of the cells was tipped off with nitrocellulose (De Curtis and Simons, 1989) to gain access to the cytoplasm. The opened cells were then treated with the M3A5 antibody against [3COP followed by gold-labeled second antibody, and then the cells were processed for electron microscopy. Fig. 2 shows that the anti-[3COP antibody, but not the control antibody, specifically labeled early endosomes containing internalized HRP.
In Vitro Budding of Endosomal Carrier Vesicles
The fact that 13 and eCOP were present in both early and late endosomal fractions (Fig. 1 A) suggested that these The Journal of Cell Biology. Volume 133, 1996 proteins may be involved in membrane transport between early and late endosomes. We, therefore, decided to establish an in vitro assay measuring ECV formation and to make use of the large panel of antibodies available against [3COP to test whether the protein was involved in this process.
Cells were incubated for 5 min at 37°C in the presence of HRP, to provide a marker of the early endosomal content. Early endosomes were then separated from the lighter ECVs and late endosomes, using the flotation gradient. In the assay, these early endosomal fractions were incubated at 37°C in the presence of ATP and cytosol, to allow formation of ECVs from early endosomes to occur in vitro. The mixture was then loaded on a similar flotation gradient, to separate ECVs formed in vitro from the denser donor membranes (early endosomes). After centrifugation, the H R P activity of the FF (containing vesicles formed in vitro) and PF (containing donor membranes) was quantified. Thus, the assay measures the percentage of the total early endosomal content entrapped within vesicles formed in the assay.
As shown in Fig. 3 A, vesicle formation in vitro occurred at 37°C, but not at 4°C, and required both cytosol and ATP. The process was rapid (Fig. 3 B) , like other budding events in vitro (Salamero et al., 1990; Rexach and Schekman, 1991) : within 5-10 min ~10% of the original early endosomal volume was entrapped within vesicles formed in vitro. We also observed that vesicle formation was inhibited by low concentrations of GTP~/S (Fig. 3 A and see Discussion). Addition of GTP~S, or any one of the other treatments, had no effect on the sedimentation properties of early or late endosomal membranes in continuous sucrose gradients (data not shown). Western blotting of SDS gels with two different anti-13COP antibodies showed that vesicles formed in vitro contained [3COP, as predicted (Fig. 3 C) . The low amounts of ERGIC53 originally present in the early endosomal fraction (Fig. 1 ) remained associated to donor membranes after the assay (Fig. 3 C) . Finally, ECVs formed in vitro contained <5% of the amounts of rab5 and transferrin receptor remaining in donor membranes after the assay (Fig.  3 C) . These observations indicate that the floated fraction was not contaminated with early endosomal vesicles, and that both rab5 and the transferrin receptor were excluded from ECVs formed in vitro, as in vivo. These experiments also show that the floated fraction did not contain recycling vesicles destined to carry the transferrin receptor back to the plasma membrane. were prepared by flotation on a sucrose gradient, as in Fig. 1 . In the assay, early endosomal fractions were diluted with cytosol and incubated for 30 min at 37°C. Vesicles formed in vitro were then separated from donor early endosomes by flotation in a single step gradient. After centrifugation, early endosomes were recovered in the pellet, whereas vesicles formed in vitro were collected at the 25 % sucrose/homogenization buffer interface, where ECVs formed in vivo equilibrate (Aniento et al., 1993a) . Then, HRP activity was quantified in the fractions, and the efficiency of vesicle formation is expressed as a percentage of the total HRP activity originally present in the donor early endosomal fraction. Control, assay carried out at 37°C in the presence of cytosol and ATP; -ATP, ATP was omitted; -cytosol, cytosol was omitted; 4°C, the assay was at 4°C; GTPTS, 10 ~M GTP~/S was present in the assay. (B)
The assay was carried out as in A for the indicated time periods. (C) The assay was as in A, but the fractions were analyzed by SDS-PAGE followed by Western blotting with antibodies against the transferrin receptor (TfnR), rab5 (rabS), ERGIC53 and two different anti-13COP antibodies (M3A5 and El). FF, the floated fraction containing ECVs formed in vitro; PF, the pelleted fraction containing donor early endosomes. For comparison, endosomal fractions prepared as in Fig. 1 are also shown.
EE, early endosomal fraction; LE, late endosomal fraction containing both late endosomes and ECVs (Aniento et al., 1993a) . Each lane contained 15 Ixg protein, corresponding to ~-2× as much HRP in LE and FF fractions, when compared to EE and PF fractions, respectively.
A morphological analysis showed that the HRP-labeled structures present in the floated fraction were predominantly multivesicular with the characteristic appearance of ECVs, as expected, whereas the donor fraction contained a large proportion of typical tubular-and ring-shaped early endosomal elements (Fig. 4, A and B, see Table I ). The complete assay mixture was then incubated without or with GTP~/S, which increases 13COP association to endosomes (Fig. 1 C) but blocks vesicle formation (Fig. 3 A) , and then analysed by immunoelectron microscopy using anti-13COP antibodies (Fig. 4, C and D) . Under both conditions, [3COP was detected on HRP-labeled early endosomal membranes, including at the neck of multivesicular structures resembling forming ECVs. The epitope may be less accessible on the ECVs, since ECV labeling with these antibodies was low. Small (<100 nm) ~COP-coated vesicles with the characteristic appearance of biosynthetic COP-coated vesicles (see Kreis and Pepperkok, 1994) were not seen in these preparations. Nor did we observe an endosomal coat with the typical appearance of the Golgi COP coat, even after tannic acid treatment of the samples to enhance coat visualization (Orci et al., 1986) . These experiments confirm the presence of [3COP on endosomes, but also suggest that the endosomal COP coat does not only differ in composition but also in morphology and/or appearance from the biosynthetic COP coat.
Endosomal Carrier Vesicles Formed In Vitro Are Fusogenic with Late Endosomes
We had previously shown that ECVs formed in vivo undergo fusion with late endosomes in vitro, in contrast to early endosomes (Bomsel et al., 1990; Aniento et al., 1993a ). Here, we tested whether ECVs which were formed in vitro from early endosomes had acquired the capacity to undergo fusion with late endosomes. Fusion was measured by the formation of a fusion-specific complex between bHRP and avidin Aniento et al., 1993a) . ECVs were formed in vitro exactly as described above (see Fig. 3 , FF), except that bHRP was used instead of H R P to label the endosomal content. As a control, we also measured the fusion properties of the bHRP-labeled donor early endosomes before (EE) and after (PF) budding in vitro. In the fusion assay, the total bHRP activity of each fraction was identical to that of the ECV fraction, so that different experiments could be directly compared. Then, the bHRP-labeled vesicles were mixed with endosomes containing internalized avidin (Aniento et al., 1993a) , cytosol and ATP, and then incubated for 45 min at 37°C. If fusion occurred, a complex was formed between bHRP and avidin. At the end of the experiment, the complex was immunoprecipitated with anti-avidin antibodies in the presence of detergent and the enzymatic activity of bHRP was quantified.
As shown in Fig. 5 , ECVs formed in vitro have acquired the capacity to undergo fusion with late endosomes (FF-LE), fusion efficiency being similar to the value measured with freshly prepared ECVs (Aniento et al., 1993a) . As previously reported for freshly prepared ECVs (Bomsel et al., 1990; Aniento et al., 1993a) , interactions between ECVs formed in vitro and late endosomes were facilitated by the presence of polymerized microtubules (not shown). The donor membranes recovered after in vitro budding (PF) retained the typical capacity of the original early endosomes (EE) to undergo homotypic fusion with other early endosomal elements (PF-EE and EE-EE) . In addition, the direct fusion of donor membranes with late endosomes was comparatively low, whether the donor was tested before (EE-LE) or after (PF-LE) the budding assay, in agreement with our previous observations Aniento et al., 1993a) . The low fusion signal which was then detected may be due to a low contamination of the early endosomal fraction with ECVs, or to the formation of new ECVs during the fusion assay (-~10% of the early endosomal vol-
Figure 4. Electron microscopy analysis of donor membranes (PF) and vesicles formed in vitro (FF). (A and B)
The assay was carried out as in Fig. 3 A, and then analyzed after Epon embedding. Main panels show low magnification overviews of HRPlabeled elements in the pelleted (,4) and floated (B) fractions. The HRP-labeled profiles comprise tubules, ring-shaped structures (arrows) and spherical multivesicular bodies (arrowheads). Early endosomal elements with a ty~pical ringshaped appearance are present in the donor pelleted fraction (higher magnification in inset to A). When compared to the donor pelleted fraction, the floated fraction is enriched in spherical multivesicular structures (higher magnification in insets to B, see Table I ). Use of tannic acid in an attempt to stain coats associated with the large vesicles revealed no significant COP-like coat. Some electron dense material was however associated with some multivesicular vesicles (B, inset, small arrowheads). Bars, 0.5 Fig. 3 A in the presence of the M3A5 anti-13COP antibody with (D) or without (C) 10 I.LM GTP~/S. The mixture containing donor membranes was then incubated with second antibodies and protein A-gold, and embedded in Epon using a method to reveal any coat material. Specific labeling is associated with HRP-labeled buds and tubules (large arrowheads) but rarely with the HRPlabeled multivesicular domains of early endosome (small double arrowheads). However, panels C (top right corner, no GTP~/S) and D (with GTP~S) show examples of 13COP labeling at the neck of structures resembling forming ECVs. Bars, 100 nm. u m e is e n t r a p p e d within newly formed E C V s in vitro; Fig.  3 A) . O u r data thus indicate that the fusion properties of both E C V s formed in vitro a n d d o n o r e n d o s o m e s (recovered after in vitro budding) are characteristic of the corresponding c o m p a r t m e n t s ; A n i e n t o et al., 1993a) and establish that functional E C V s are formed from early e n d o s o m e s in vitro.
~m (A-D) and 0.2 i~m (insets). (C and D) The assay was carried out as in
Formation of E C V s Depends on flCOP
W e then tested whether [3COP was involved in E C V form a t i o n from early endosomes. In these experiments, vesicles were formed in vitro as described above, except that the reaction mixture was p r e i n c u b a t e d for 60 rain on ice with antibodies against [3COP, before raising the temperature to 37°C. As shown in Fig. 6 A, formation of E C V s was inhibited by a polyclonal (D1) or by a m o n o c l o n a l ( m a D ) a n t i b o d y against the same [3COP peptide, or by an antic o a t o m e r a n t i b o d y (CM1A10). T h e process was also completely abolished by the M 3 A 5 m o n o c l o n a l a n t i b o d y against [3COP. The specificity of inhibition observed with these antibodies is entirely consistent with our other biochemical a n d morphological observations. The m a D and M3A5 could also be used for e n d o s o m e i m m u n o i s o l a t i o n (Fig. 1 , D a n d E) a n d i m m u n o l a b e l i n g (Figs. 2 and 4) , whereas the C M 1 A 1 0 could be used for i m m u n o d e p l e t i o n of cytosolic C O P s (see Fig. 6 C) , as previously shown by Cells were incubated with HRP for 5 min at 37°C to label early endosomes, and homogenized. Then, early endosomes were purified by flotation in the step gradient. In the assay, these early endosomes were incubated at 37°C in the presence of cytosol and ATP, to allow formation of ECVs to occur in vitro (as in Fig. 3 ). Donor early endosomes were separated from ECVs after centrifugation in a similar gradient. Membranes were then sedimented, fixed, and processed for electron microscopy, as in . The profiles containing internalized HRP were analyzed. According to their morphology in thick sections, HRP-positive structures were counted as tubular, ring-shaped, or spherical elements (see Fig. 4 ). The number of profiles for each category is indicated as a percentage of the total number of labeled structures in each fraction, donor early endosomes present in the pelleted fraction (Donor EE) or vesicles formed in vitro present in the floated fraction (Budded vesicles). somes. The assay measuring vesicle formation in vitro was carried out essentially as in Fig. 3 , except that the reaction mixture (adjusted to 25% sucrose) was loaded onto a 35% sucrose cushion to avoid possible damage to the donor membranes after pelleting. Thus, after centrifugation, donor early endosomal membranes (PF) were recovered at the 35/25% sucrose interface, whereas
ECVs formed in vitro (FF) were collected at the interface between 25% sucrose and homogenization buffer. In a second step, the fusion activity of FF and PF fractions with late endosomes (LE, see Fig. 1 ) was quantified using our in vitro fusion assay (Aniento et al., 1993a) . The results are compared with the fusion activity of freshly prepared early endosomes (EE, see Fig. 1 bodies, suggest that 13COP is involved in the formation of ECVs from early endosomes. As a next step, we tested the effects of COP depletion on vesicle formation in the assay. The cytosol was immunodepleted using the CM1A10 anti-coatomer antibody (Fig. 6 C) , which has been previously used to immunodeplete coatomer (Orci et al., 1993b) . After immunodepletion, other cytosolic properties required for vesicle formation were not altered, since depleted cytosol supported the formation of ECVs from control untreated membranes (not shown). Since COPs are also present on endosomal membranes, cells were treated with nigericin before fractionation to release endosome-associated COPs (Fig. 6 C; see below and Fig. 7 A) . Membrane depletion was reversible, since vesicle formation then occurred at control levels in the presence of untreated cytosol when nigericin was omitted in the assay (Fig. 6 B, controls) . Fig. 6 B shows that depletion of both cytosolic and membrane pools of 13COP significantly inhibited vesicle formation in the assay. To ensure that these treatments were reversible, low amounts of complete cytosol containing COPs were added to the assay. Then, vesicle formation from early endosomes was fully restored (Fig. 6 B) . This effect was not due to the presence of some factors with general stimulating activity, since addition of extra cytosol to the controls did not further increase vesicle formation. To test the involvement of COP proteins more directly, a high speed pellet highly enriched in COPs was prepared after centrifugation of the cytosol (not shown), as established by F. Wieland (personal communication). Centrifugation did not alter other cytosolic properties, since the high speed supernatant still supported both ECV formation from undepleted membranes as well as endosome fusion in vitro (not shown). As shown in Fig. 6 B, the COP-enriched fraction could restore ECV formation after depletion of both cytosolic and membrane pools of COPs. Altogether, these depletion-recomplementation experiments, together with the effects of anti-13COP antibodies in the assay, demonstrate that COPs, in particular 13COP, are necessary for the formation of vesicles mediating transport from early to late endosomes. Orci et al. (1993b) . In contrast, the A1 antibody had no effect in the assay, suggesting that this epitope is not accessible on endosomal membranes.
As a control, we also tested in the assay antibodies against the small GTPase rab5, which inhibit early endosome fusion in vitro , and against the small GTPase rab3a, which is present on synaptic vesicles (Fischer von Mollard et al., 1991) . We also tested antibodies against clathrin-associated a adaptin, and against both 131 and 132 adaptins (Robinson, 1992) . None of these antibodies had any effect on ECV formation from early endosomes (Fig. 6 A) . Finally, as an additional control, we also tested the same antibodies in our assay measuring homotypic fusion of early endosomes . Whereas fusion was inhibited by anti-rab5 antibodies, as expected , none of the other antibodies, including those against 13COP, had any effect on endosome fusion (not shown). The fact that anti-13COP antibodies block ECV formation from early endosomes but not early endosome fusion, in contrast to anti-rab5 anti-
E C V Formation Is Sensitive to the Vacuolar pH
Our previous observations had shown that ECV formation is abolished after inhibition of the vacuolar ATPase in vivo, whereas internalization into and recycling from early endosomes in vivo, or the fusion properties of early endosomes in vitro are not affected (Clague et al., 1994) . We therefore measured whether in vitro budding also required an active vacuolar ATPase. In our assay, ECV formation was inhibited to the same extent in the presence of 10 p~M bafilomycinA1 or 100 nM concanamycinB (Fig. 7  A) , two specific inhibitors of the vacuolar ATPase (Bowman et al., 1988; Woo et al., 1992; Villa et al., 1993) . The extent of inhibition was similar when cells were pretreated with either drug in vivo, or when the drug was directly added to the assay in vitro. However, a combination of both treatments caused a more pronounced inhibition, presumably because of a more efficient neutralization of the endosomal pH (Yoshimori et al., 1991; Clague et al., 1994) . In addition, replacement of KCI in the budding as- The assay measuring ECV formation in vitro was carried out as described in the legend of Fig. 3 , except that the mixture was preincubated for 60 rain on ice with the indicated antibodies. Control, no addition; P5D4, control antibody as in Fig. 1 (D and E) ; anti-rab3a, antibody against the small GTPase rab3a; anti-rab5, antibody against the small GTPase tab5; anti-a adaptin, antibody against a adaptin; anti-ill ~2 adaptin, antibody against both 131 and 132 adaptins; M3A5, maD, A1, D1, antibodies against 13COP; CMIAIO, anti-coatomer antibody. Vesicle formation is expressed as a percentage of the controls. (B) Vesicle formation in vitro (as in Fig. 3 ) was measured after COP depletion. To deplete endogenous COPs associated to endosomes, cells were pretreated with 10 ~M nigericin (see panel C and Fig. 7 ). This treatment was reversible, since ECV formation in vitro was restored by control rat liver cytosol, which had been incubated for 90 min with an irrelevant antibody (P5D4) and then for 1 h with protein A-Sepharose coupled to rabbit anti-mouse IgG (control, see C). To deplete cytosolic coatomers, the cytosol was incubated as above, but with the CM1A10 anti-coatomer antibody (depleted, see C). ECV formation was inhibited after depletion of both endosomal and cytosolic pools of COPs. ECV formation could be restored by the addition of 25% (Ixg/txg) untreated cytosol to the assay (complete cytosol), but not by COP-depleted cytosol (depleted cytosol). Addition of extra cytosol had no effects on the controls. ECV formation could also be restored after addition of a coatomer-enriched fraction prepared by high speed centrifugation of the cytosol (coatomer HSP). (C) SDSgel and Western blotting analysis of 13 and eCOP distribution in cytosol and early endosomes (EE) prepared as in B.
say with KOAc decreased the efficiency of vesicle budding, in agreement with the role of Cl-channels in maintenance of an acidic lumenal pH (Mellman et al., 1986) , and with the finding that loss of function of the cystic fibrosis transmembrane regulator, which causes defective C1-conductance, delays o~2-macroglobulin degradation (Barasch et al., 1991) . Finally, we used nigericin, an ionophore which exchanges protons and K + ions, to dissect the acidogenic and electrogenic properties of the vacuolar ATPase (Mellman et al., 1986) . The inhibition observed in the presence of the drug (Fig. 7 A) demonstrates that vesicle formation in vitro was inhibited by neutralization of the lumenal pH.
[3COP Association to Endosomes Is Sensitive to the Vacuolar pH
We then investigated whether 13COP association to endosomal membranes was also sensitive to the lumenal pH. In these experiments, endosomes immunoisolated using the VSV-G protein as antigen were treated in the presence of cytosol under the same conditions as in the in vitro assay.
A quantitative Western blot analysis using different anti-13COP antibodies showed that the amounts of 13COP associated to early endosomal membranes were reduced to 55 _-+ 5% of the control value by bafilomycinA1, to 35 _+ 5% by concanamycinB, and to 15 _ 3% by nigericin (Fig. 7 B) . We also used immunogold labeling and electron microscopy to quantify the amounts of 13COP present on early endosomes after neutralization of the lumenal pH with concanamycinB or bafilomycinA1 (not shown). These studies also showed that only 30 _+ 8% of the amounts of 13COP present on control membranes remained associated to early endosomes after either drug treatment. The drugs did not cause endosome fragmentation, since 100 __+ 5% of the transferrin receptor present in the control remained associated to immunoisolated endosomes after each treatment (Fig. 7 B) . Neither did the drugs release rab5, which normally cycles between cytosol and membranes (Zerial and Stenmark, 1993) , or annexinlI, a peripheral protein of the early endosomal membrane (Emans et al., 1993) ; for both proteins, 95 _-+ 5% of the amounts present in the control remained associated to endosomes after each treatment. This lumenal pH dependence was specific to endosomes, since COP association, including ",/COP, to ERGIC53-containing membranes (HM in Fig. 1 A) was not affected by the drugs (not shown). Finally, these drugs also caused COPs to be released from endosomal membranes in vivo, as illustrated by the effects of nigericin on 13 and ~COP (Fig. 6 C) . Therefore, we conclude that the for- Chloride, when indicated ( -) KC1 was replaced with KOAc; Baf A1 in vivo, the cells were pre-treated with 1 p.M bafilomycin A1 for 30 min at 37°C, before HRP internalization; BafA1, Con. B, and Nigericin, the donor early endosomal fraction was treated in vitro with the indicated concentrations of bafilomycin A1, concanamycin B or nigericin for 15 rain at 4°C in the absence of ATP, and then for 15 min in the presence of ATP and cytosol, before raising the temperature to 37°C. (B) Immunoisolated early endosomes, prepared as in Fig. 1 B, were treated in vitro with 10 txM bafilomycin A1, 100 nM concanamycin B, or 50 p~M nigericin as in A. Then, endosomal membranes were collected by centrifugation and analyzed by SDS-PAGE followed by Western blotting with the M3A5 or E1 antibodies against 13COP, or antibodies against rab5, the transferrin receptor and annexinlI. Each lane contained =10 txg protein.
mation of ECVs from early endosomes depends on 13COP or a closely related 13COP homologue, and that this process is regulated by the acidification properties of early endosomes.
Discussion
We have previously shown that, both in polarized and nonpolarized cells, membrane transport from early to late endosomes occurs via vesicular intermediates which we termed ECVs Bomsel et al., 1990; Aniento et al., 1993a) . Similar vesicles also mediate transport from early to late endosomes both in the axons and in the dendrites of cultured neurons (Parton et al., 1992) . In this paper we show that some, but not all, COPs are present on endosomal membranes and are involved in the formation of ECVs from early endosomes in vitro. We observe that neutralization of the endosomal pH either with specific inhibitors of the vacuolar ATPase or with the ionophore nigericin causes both a decrease in the amounts of COPs associated to early endosomes and an inhibition of the formation of ECVs from early endosomes. These experiments suggest that a COP subcomplex is part of the mechanism regulating membrane transport from early to late endosomes, and that membrane association of endosomal COPs depends on the acidic properties of the endosomal milieu.
Formation of ECVs from Early Endosomes
We have used an in vitro assay to reconstitute the formation of ECVs from early endosomes. We find that ~10% of a fluid phase tracer internalized for 5 min at 37°C in vivo is packaged within vesicles formed in vitro with a tla ~5 min. Our previous studies indicated that a similar fraction of the early endosomal content is packaged within ECVs over a 5-10-rain time period in vivo . These observations may indicate that a single round of vesicle formation was reconstituted in the assay. This process depends on the presence of cytosol and ATP and is inhibited at low temperature. Vesicles formed in vitro do not originate from the simple fragmentation of early endosomes, since they do not contain the small GTPase rab5, which is restricted to the plasma membrane and early endosomes in vivo even after 10--50-fold overexpression (Chavrier et al., 1990 Gorvel et al., 1991) . Nor are these vesicles recycling endosomal vesicles, since they lack the transferrin receptor, a marker of the recycling pathway (Hopkins, 1983; Stoorvogel et al., 1987; Mayor et al., 1993; Ghosh and Maxfield, 1995) . Additional evidence that vesicles formed in vitro are not recycling vesicles comes from our observations that vesicle formation is inhibited after neutralization of the lumenal pH, as is ECV formation in vivo. In contrast, recycling of the endosomal content back to the cell surface is not sensitive to the lumenal pH (Clague et al., 1994) . Finally, evidence that functional ECVs are formed from early endosomes in vitro comes from our observations that these vesicles are fusogenic with late endosomes, like ECVs formed in vivo (Aniento et al., 1993a; Bomsel et al., 1990) . Our data argue against a gradual change of the membrane composition during passage from early to late endosomes (Stoorvogel et al., 1991) . Indeed, ECVs, but not donor early endosomes, have acquired the capacity to dock onto and fuse with late endosomes, and these ECVs exclude both rab5 and the transferrin receptor. Our data, thus, suggest that a strict compartment boundary exists on early endosomal membranes at the site of ECV formation.
Coats and Endosomes
With the exception of plasma membrane clathrin-coated pits, little is known about the role of coat proteins in the endocytic pathway. Morphological studies have shown the presence of small clathrin-coated pits on early endosomal membranes, presumably involved in receptor recycling back to the cell surface (Killisch et al., 1992) . Non clathrin coats have also been observed on early endosomes (Parton, R., unpublished observations), but the function of these coats is unknown. In addition, expression of ~COP, a component of the COP coat required at early stages of the biosYnthetic pathway (Kreis and Pepperkok, 1994) , was recently shown to correct pleiotropic membrane transport defects, including in the endocytic pathway, in the CHO ldlF mutant cell line (Guo et al., 1994; Hobbie et al., 1994) .
Our studies show that I3COP, another component of the COP coat, is present on early endosomes and is required for the formation of ECVs, the vesicular intermediates destined for late endosomes. Consistent with the findings of Guo et al. (1994) , we find that ~COP is also present on endosomes. However, all COP subunits do not appear to be shared by the endocytic and the biosynthetic pathways, since ~,COP is not detected in any of our different endosome preparations. These observations are also in good agreement with the finding that [3, ~, and [COP, but not ~COP, are associated to endosomes prepared by free-flow electrophoresis (Whitney, J.A., M. Gomez, T.E. Kreis, and I. Mellman, manuscript submitted for publication). Although the precise function of endosomal COPs is not established, our data, examined in the light of the known roles of coat proteins (Kreis and Pepperkok, 1994; Robinson, 1994) , suggest that endosomal COPs contribute to coat formation during vesicle transport from early to late endosomes.
Endosomal and Biosynthetic COPs
We find that some, but not all, antibodies against [3COP can inhibit ECV formation in vitro, suggesting that some epitopes only are accessible to antibodies when the protein is bound to endosomal membranes. These observations may also suggest that endosomal and biosynthetic forms of [3COP are, at least to some extent, immunologically distinct. Indeed, several [3COP isoforms have been found in high resolution two-dimensional gels (Celis et al., 1994) , presumably reflecting the existence of different post-translational modifications. More importantly, the presence of [3, [, and ¢COP, but not "yCOP, on endosomes suggests that coatomer subcomplexes can exist, and that 13, [, and ¢COP may be part of the same subcomplex on endosomal membranes. Presumably, this subcomplex is associated to other, as yet unknown, components on endosoreal membranes.
The mechanisms regulating both COP association to endosomes and ECV formation differ, at least to some extent, from those regulating the formation of COP-coated vesicles in the biosynthetic pathway. Both ECV formation and COP association to endosomes are sensitive to the lumenal pH. In contrast, biosynthetic COP-coated vesicles form on the membranes of nonacidic compartments (Mellman et al., 1986) , and COP association to ERGIC53-enriched membranes is pH insensitive. We also find that ECV formation is inhibited by GTP~tS, as is the formation of plasma membrane-derived clathrin-coated vesicles (Carter et al., 1993) and secretory granules , but in contrast to the budding of COP-or COPII-coated vesicles (Ostermann et al., 1993; Barlowe et al., 1994) . However, COP binding to endosomes is increased by GTP-/S, as is the case for Golgi membranes (Donaldson et al., 1990; Donaldson et al., 1992; Helms and Rothman, 1992; Palmer et al., 1993) . On Golgi membranes, both COP recruitment and vesicle formation are stimulated by GTP'yS via the small GTP-binding protein ARF1 (see Kreis and Pepperkok, 1994 ). Since we find that GTP~/S stimulates COP association to endosomes but inhibits ECV formation, it appears that these two processes are uncoupled in the endocytic pathway, presumably because they are regulated by more than one GTP-binding protein. Alternatively, COP association to endosomes may be regulated by an ARF with properties distinct from ARF1. Indeed, membrane association of ARF6, which has been implicated between plasma membrane and early endosomes, does not depend on the bound nucleotide state and is insensitive to brefeldinA, in contrast to ARF1 (Peters et al., 1994) .
Altogether, our observations indicate that the association of endosomal and biosynthetic COPs to membranes shares similar GTP dependence but is regulated, at least in part, by different mechanisms. Since COP subunits are only partially shared by endosomal and biosynthetic membranes, one may speculate that mechanistic similarities and differences reflect the presence of common and specific coat components, respectively.
Acidification, Membrane Transport, and COPs
Our data show that COPs are directly involved in the formation of ECVs. Neutralization of the endosomal pH reduces the amounts of COPs associated to endosomal membranes, and concomitantly inhibits the formation of ECVs in vitro, as we had observed in vivo (Clague et al., 1994) . These observations suggest that the acidification properties of BHK early endosomes may control the formation of vesicles destined for late endosomes by controlling coat recruitment onto the membranes. This mechanism is consistent with the fact that the lumenal pH drops from early to late endosomes (Mellman et al., 1986) and with the observation that ECVs can be more acidic than early endosomes (Killisch et al., 1992) . It is not clear how information on the lumenal pH may then be transferred to the cytoplasmic face of the membrane. The simplest view is that pH differences may be sensed by the conformational change of a membrane protein. Indeed, the conformation of trans-membrane proteins can be sensitive to the endosomal pH (Watts, 1984) . We, therefore, speculate that the conformation of an endosomal trans-membrane protein, possibly a COP receptor, is pH sensitive, and thus serves as a sensor of the endosomal pH.
In conclusion, formation of transport vesicles at the early endosomal membrane appears to be regulated by COP recruitment on the membrane in a process dependent on the acidic milieu of early endosomes. This mechanism, which is also regulated by GTP-binding proteins, but not by tab5 present on early endosomes, may provide an appropriate means to regulate the formation of these relatively large and multivesicular carriers Bomsel et al., 1990; Aniento et al., 1993a) . One of our future goals will be to make use of our approach to study in more detail the formation of these vesicular intermediates, and, in particular, the precise role of coat proteins in this process.
